Silenor Tablet
Product Images NDC 42847-106

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Silenor (NDC 42847-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Currax Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Silenor 01)

Chemical structure of doxepin hydrochloride, the active ingredient in Silenor tablets. The diagram illustrates the molecular bonds and composition of the compound.*

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

Silenor 3 mg doxepin tablets packaging label showing a bottle containing 30 tablets. The label highlights the strength of 3 mg, the product name Silenor with doxepin tablets indicated, and includes the NDC 42847-103-30. Distributed by Currax Pharmaceuticals LLC, the label contains storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Label for Silenor 6 mg doxepin tablets, oral tablet prescription drug by Currax Pharmaceuticals LLC. The label indicates a 30-tablet quantity and displays the NDC 42847-106-30. The label includes dosage information, storage instructions at 20°-25°C, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.